OLR1 explained

Oxidized low-density lipoprotein receptor 1 (Ox-LDL receptor 1) also known as lectin-type oxidized LDL receptor 1 (LOX-1) is a protein that in humans is encoded by the OLR1 gene.[1]

LOX-1 is the main receptor for oxidized LDL on endothelial cells, macrophages, smooth muscle cells,[2] and other cell types.[3] But minimally oxidized LDL is more readily recognized by the TLR4 receptor, and highly oxidized LDL is more readily recognized by the CD36 receptor.[4]

Function

LOX-1 is a receptor protein which belongs to the C-type lectin superfamily. Its gene is regulated through the cyclic AMP signaling pathway. The protein binds, internalizes and degrades oxidized low-density lipoprotein.

Normally, LOX-1 expression on endothelial cells is low, but tumor necrosis factor alpha, oxidized LDL, blood vessel shear stress, and other atherosclerotic stimuli substantially increase LOX-1 expression.[5]

LOX-1 may be involved in the regulation of Fas-induced apoptosis. Oxidized LDL induces endothelial cell apoptosis through LOX-1 binding. Other ligands for LOX-1 include oxidized high-density lipoprotein, advanced glycation end-products, platelets, and apoptotic cells.[5] The binding of platelets to LOX-1 causes a release of vasoconstrictive endothelin, which induces endothelial dysfunction.[5]

This protein may play a role as a scavenger receptor.

Clinical significance

Binding of oxidized LDL to LOX-1 activates NF-κB, leading to monocyte adhesion to enthothelial cells (a pre-requisite for the macrophage foam cell formation of atherosclerosis). Macrophage affinity for unmodified LDL particles is low, but is greatly increased when the LDL particles are oxidized.[6] LDL oxidation occurs in the sub-endothelial space, rather than in the circulation. But oxidized cholesterol from foods cooked at high temperature can also be a source of oxysterols.

Mutations of the OLR1 gene have been associated with atherosclerosis, risk of myocardial infarction, and may modify the risk of Alzheimer's disease.[7] When applied to human macrophage-derived foam cells in vitro, the dietary supplement berberine inhibits the expression of the ORL1 gene in response to oxidized low-density lipoprotein cholesterol,[8] but this has not yet been demonstrated in a living animal or human.

Further reading

Notes and References

  1. Li X, Bouzyk MM, Wang X . Assignment of the human oxidized low-density lipoprotein receptor gene (OLR1) to chromosome 12p13.1→p12.3, and identification of a polymorphic CA-repeat marker in the OLR1 gene . Cytogenet Cell Genet . 82 . 1–2 . 34–6 . Nov 1998 . 9763655 . 10.1159/000015059 . 46772688 .
  2. Pirillo A, Norata GD, Catapano AL . LOX-1, OxLDL, and atherosclerosis . Mediators of Inflammation . 2013 . 1–12 . 2013 . 10.1155/2013/152786 . 3723318 . 23935243 . free .
  3. Xu S, Ogura S, Chen J, Little PJ, Moss J, Liu P . LOX-1 in atherosclerosis: biological functions and pharmacological modifiers . . 70 . 16 . 2859–2872 . 2013 . 10.1007/s00018-012-1194-z . 23124189 . 4142049 .
  4. Zmysłowski A, Szterk A . Current knowledge on the mechanism of atherosclerosis and pro-atherosclerotic properties of oxysterols . Lipids in Health and Disease . 16 . 1 . 188 . 2017 . 10.1186/s12944-017-0579-2 . 5625595 . 28969682 . free .
  5. Kakutani M, Masaki T, Sawamura T . A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 . . 97 . 1 . 360–364 . 2000 . 10.1016/j.biochi.2016.10.010 . 26668 . 10618423. 2000PNAS...97..360K .
  6. Brites F, Martin M, Guillas I, Kontush A . Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit . . 8 . 66–77 . 2017 . 10.1016/j.bbacli.2017.07.002 . 5597817 . 28936395 .
  7. Web site: Entrez Gene: OLR1 oxidized low density lipoprotein (lectin-like) receptor 1.
  8. Guan S, Wang B, Li W, Guan J, Fang X. Effects of berberine on expression of LOX-1 and SR-BI in human macrophage-derived foam cells induced by ox-LDL. Am J Chin Med. 2010. 38. 6. 1161–9. 21061468. 10.1142/s0192415x10008548.